The Journal for Nurse Practitioners
Volume 4, Issue 3 , Pages 194-200 , March 2008

Diagnosis and Treatment of Anemia of Chronic Kidney Disease in the Primary Care Setting: A Primer for Nurse Practitioners

  • Cheryl Dalton

      Affiliations

    • Cheryl Dalton, BSN, RN, CNN, CCRC, is a nephrology research nurse in the section of nephrology at West Virginia University School of Medicine, Morgantown, West Virginia. discloses receiving grant/research support from Roche Laboratories.
    • ,
  • Rebecca Schmidt

      Affiliations

    • Rebecca Schmidt, DO, FACP, FASN, is professor and chief of the section of nephrology at West Virginia University School of Medicine, Morgantown, West Virginia. She discloses receiving grants/research support from Roche Laboratories and serving as a consultant to Roche, Ortho Biotech, and Amgen.

References 

  1. Coresh J , Byrd-Holt D , Astor BC , et al.   Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000 . J Am Soc Nephrol . 2005;16(1):180–188
  2. National Kidney Foundation  . KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification . Am J Kidney Dis . 2002;39(2 suppl 1):S1–S266
  3. National Kidney Foundation—Kidney Early Evaluation Program  . KEEP Annual Data Report 2006 . Am J Kidney Dis . 2007;49(3 suppl 3):S1–S160
  4. Levey AS , Coresh J , Balk E , et al.   National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification . Ann Intern Med . 2003;139(2):137–147
  5. McClellan W , Aronoff SL , Bolton WK , et al.   The prevalence of anemia in patients with chronic kidney disease . Curr Med Res Opin . 2004;20(9):1501–1510
  6. Snyder S , Pendergraph B . Detection and evaluation of chronic kidney disease . Am Fam Physician . 2005;72(9):1723–1732
  7. Stevens LA , Fares G , Fleming J , et al.   Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: evidence for lack of physician awareness of chronic kidney disease . J Am Soc Nephrol . 2005;16(8):2439–2448
  8. Hsu CY , McCulloch CE , Curhan GC . Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey . J Am Soc Nephrol . 2002;13(2):504–510
  9. Deicher R , Horl WH . Anaemia as a risk factor for the progression of chronic kidney disease . Curr Opin Nephrol Hypertens . 2003;12(2):139–143
  10. Donnelly S . Why is erythropoietin made in the kidney? The kidney functions as a critmeter . Am J Kidney Dis . 2001;38(2):415–425
  11. Thomas MC , Tsalamandris C , MacIsaac RJ , Jerums G . The epidemiology of hemoglobin levels in patients with type 2 diabetes . Am J Kidney Dis . 2006;48(4):537–545
  12. National Kidney Foundation  . KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease . Am J Kidney Dis . 2006;47(5 suppl 3):S11–S145
  13. Iaina A , Silverberg DS , Wexler D . Therapy insight: congestive heart failure, chronic kidney disease and anemia, the cardio-renal-anemia syndrome . Nat Clin Pract Cardiovasc Med . 2005;2(2):95–100
  14. Walker AM , Schneider G , Yeaw  , et al.   Anemia as a predictor of cardiovascular events in patients with elevated serum creatinine . J Am Soc Nephrol . 2006;17(8):2293–2298
  15. Roman RM , Lobo PI , Taylor RP , et al.   Prospective study of the immune effects of normalizing the hemoglobin concentration in hemodialysis patients who receive recombinant human erythropoietin . J Am Soc Nephrol . 2004;15(5):1339–1346
  16. Revicki DA , Brown RE , Feeny DH , et al.   Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients . Am J Kidney Dis . 1995;25(4):548–554
  17. Nissenson AR . Epoetin and cognitive function . Am J Kidney Dis . 1992;20(1 suppl 1):21–24
  18. De Santo RM , Bartiromo M , Cesare MC , Di Iorio BR . Sleeping disorders in early chronic kidney disease . Semin Nephrol . 2006;26(1):64–67
  19. Lu WX , Jones-Burton C , Zhan M , et al.   Survival benefit of recombinant human erythropoietin administration prior to onset of end-stage renal disease: variations across surrogates for quality of care and time . Nephron Clin Pract . 2005;101(2):C79–C86
  20. Khan SS , Kazmi WH , Abichandani R , et al.   Health care utilization among patients with chronic kidney disease . Kidney Int . 2002;62(1):229–236
  21. Collins AJ . Anaemia management prior to dialysis: cardiovascular and cost-benefit observations . Nephrol Dial Transplant . 2003;18(Suppl 2):ii2–ii6
  22. Eckardt KU , Mollmann M , Neumann R , et al.   Erythropoietin in polycystic kidneys . J Clin Invest . 1989;84(4):1160–1166
  23. Hallan SI , Dahl K , Oien CM , et al.   Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey . BMJ . 2006;333(7577):1047
  24. Stengel B , Tarver-Carr ME , Powe NR , Eberhardt MS , Brancati FL . Lifestyle factors, obesity and the risk of chronic kidney disease . Epidemiology . 2003;14(4):479–487
  25. Stevens LA , Coresh J , Greene T , Levey AS . Assessing kidney function—measured and estimated glomerular filtration rate . N Engl J Med . 2006;354(23):2473–2483
  26. Cockcroft DW , Gault MH . Prediction of creatinine clearance from serum creatinine . Nephron . 1976;16(1):31–41
  27. KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target . Am J Kidney Dis . 2007;50(3):471–530
  28. Epogen (R) [US prescribing information] . Thousand Oaks, CA: Amgen, Inc.; 2007;
  29. Aranesp (R) [US prescribing information] . Thousand Oaks, CA: Amgen, Inc.; 2007;
  30. Macdougall IC . Recent advances in erythropoietic agents in renal anemia . Semin Nephrol . 2006;26(4):313–318
  31. Levin A , Djurdjev O , Thompson C , et al.   Canadian randomized trial of hemoglobin maintenance to prevent or delay left ventricular mass growth in patients with CKD . Am J Kidney Dis . 2005;46(5):799–811
  32. Cody J , Daly C , Campbell M , et al.   Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients . Cochrane Database Syst Rev . 2005;(3):CD003266
  33. Gouva C , Nikolopoulos P , Ioannidis JP , Siamopoulos KC . Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial . Kidney Int . 2004;66(2):753–760
  34. Jungers P , Choukroun G , Oualim  , et al.   Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients . Nephrol Dial Transplant . 2001;16(2):307–312
  35. Food and Drug Administration. Information for Healthcare Professionals  . Erythropoiesis Stimulating Agents (ESA) [Aranesp (darbepoetin), Epogen (epoetin alfa), and Procrit (epoetin alfa) . Available at: http://www.fda.gov/cder/drug/InfoSheets/HCP/RHE2007HCP.htm <<AUTHOR: Please provide the date this site was accessed.>>.
  36. Perkins R , Olson S , Hansen J , et al.   Impact of an anemia clinic on emergency room visits and hospitalizations in patients with anemia of CKD pre-dialysis . Nephrol Nurs J . 2007;34(2):167–174
  37. St Peter WL , Schoolwerth AC , McGowan T , McClellan WM . Chronic kidney disease: issues and establishing programs and clinics for improved patient outcomes . Am J Kidney Dis . 2003;41(5):903–924
  38. Goolsby MJ . National Kidney Foundation Guidelines for chronic kidney disease: evaluation, classification, and stratification . J Am Acad Nurse Pract . 2002;14(6):238–242
  39. Lea JP , McClellan WM , Melcher C , Gladstone E , Hostetter T . CKD risk factors reported by primary care physicians: do guidelines make a difference? . Am J Kidney Dis . 2006;47(1):72–77
  40. Kausz AT , Khan SS , Abichandani R , et al.   Management of patients with chronic renal insufficiency in the Northeastern United States . J Am Soc Nephrol . 2001;12(7):1501–1507

PII: S1555-4155(07)00611-3

doi: 10.1016/j.nurpra.2007.09.013

The Journal for Nurse Practitioners
Volume 4, Issue 3 , Pages 194-200 , March 2008

Article Tools